• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  04/25/2014
Trade Name:  Asmanex HFA
Generic Name or Proper Name (*):  mometasone furoate
Indications Studied:  Maintenance treatment of asthma as prophylactic therapy
Label Changes Summary:  *Approved for use in adults and pediatric patients 12 years and older *Safety and efficacy hav not been established in children less than 12 years *The growth of pediatric patients receiving orally inhaled corticosteroids should be monitored routinely *To minimize the systemic effects of orally inhaled corticosteroids each patient should be titrated to his/her lowest effective dose *Information on dosing, adverse reactions, and clinical trials *New dosage form
Product Labeling:  Labeling  Opens a new window
Sponsor:  Merck Sharp & Dohme Corp.
Therapeutic Category:  Antiasthmatic